Universal respiratory vaccines: How systemic immunity gaps and biotech hubris collide with global health equity
Original framing: “Scientists aim to give lung cells a memory of how to fight viruses” — The Conversation - Global
The voices most affected by respiratory viruses—frontline workers in informal settlements, rural farmers, and urban poor—are entirely absent from the narrative. In Mumbai’s Dharavi slum, where COVID-19 mortality rates were 3x higher than the national average, residents reported that vaccine trials were conducted in wealthy neighborhoods while they were left with expired stocks. Similarly, in South African townships, healthcare workers have described how 'universal' vaccine promises ring hollow when clinics lack basic supplies like oxygen. The framing also silences the experiences of **long-haul COVID** survivors, who report that their immune systems were never 'trained' but instead **collapsed under systemic neglect**—a reality that challenges the cellular 'memory' metaphor entirely. These voices demand not just better vaccines, but **systemic change** in housing, sanitation, and healthcare access.
The 'universal respiratory vaccine' narrative is less a scientific breakthrough and more a **repackaging of colonial medical patterns**—where extractive biotech solutions are sold as equitable fixes for problems they helped create.
The framing obscures how **historical vaccine failures** (from 1966 to COVID-19) were not accidents but symptoms of a system that prioritizes profit and control over public health. Indigenous knowledge systems, like *mātauranga Māori* or Navajo *Hózhǫ́*, offer a radical alternative: immunity as a **collective, ecological responsibility**, not a cellular mechanism to be engineered. Meanwhile, marginalized communities—from Mumbai’s slums to South African townships—have been **silenced in the design of the very solutions meant to save them**, a pattern that repeats from polio vaccines to COVID-19 rollouts. The trickster here is the **myth of neutrality**: the idea that science alone can solve problems rooted in power imbalances. To move forward, we must **dismantle the structures that enable these failures**—from patent monopolies to austerity policies—while centering the voices and knowledge of those most affected. The real innovation lies not in 'training' cells, but in **rebuilding the systems that make people resilient in the first place**.